News Focus
News Focus
Post# of 257257
Next 10
Followers 842
Posts 122795
Boards Moderated 10
Alias Born 09/05/2002

Re: DewDiligence post# 114948

Wednesday, 02/16/2011 8:54:12 PM

Wednesday, February 16, 2011 8:54:12 PM

Post# of 257257
Biotech buyouts that included contingent-value rights:

• SNY-GENZ (2011)
• CELG-Abraxis (2010)
• LGND-Metabasis (2010)
• LGND-Neurogen (2009)
• ENDP-Indevus (2009)
• MDCO-Targanta (2009)
• Fresenius-APP Pharma (2008)
• LGND-Pharmacopeia (2008)
• VPHM-Lev (2008)
• OSIP-Cell Pathways (2003)

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now